They are considered dual amylin and calcitonin receptor agonists (DACRAs) and have been studied as amylin receptor agonists in addition to research in which they were used as calcitonin receptor agonists [18,19]
These medicines include semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro, a dual GLP-1 and GIP receptor agonist)
13 Ask if the patient is experiencing, or has ever experienced, nausea and vomiting because of the GLP-1 receptor agonist therapy, and if so, document this information in the patient record
Wegovy 2.4 mg, FlexTouch solution for injection in pre-filled pen SmPC
GLP-1 levels typically peak about 30-60 minutes after eating and help regulate appetite, insulin release, and gastric emptying